The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationOperational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
Self-citationAllosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Self-citationRoles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Neubig, R. R., Spedding, M., Kenakin, T., & Christopoulos, A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.4 · Cited by 665
Self-citationAgonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Azzi, M., Charest, P. G., Angers, S., Rousseau, G., Kohout, T., Bouvier, M., & Piñeyro, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1936664100 · Cited by 523
Allosteric Modulation of the Cannabinoid CB1 Receptor
Price, M. R., Baillie, G. L., Thomas, A., Stevenson, L. A., Easson, M., Goodwin, R., McLean, A., McIntosh, L., Goodwin, G., Walker, G., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.016162 · Cited by 443
Self-citationEhlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Litschig, S., Gasparini, F., Rueegg, D., Stoehr, N., Flor, P. J., Vranesic, I., Prézeau, L., Pin, J.-P., Thomsen, C., & Kuhn, R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12169-4 · Cited by 344
Modification of the binding properties of muscarinic receptors by gallamine.
Stockton, J. M., Birdsall, N. J., Burgen, A. S., & Hulme, E. C. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14327-7 · Cited by 328
Hermans, E. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00051-2 · Cited by 327
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Self-citationWatson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
Jakubík, J., Bačáková, L., El-Fakahany, E. E., & Tuček, S. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.172 · Cited by 228
Baker, J. G., Hall, I. P., & Hill, S. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.6.1357 · Cited by 189
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.
Vanhoutte, P. M., Barnard, E. A., Cosmides, G. J., Humphrey, P. P., Spedding, M., & Godfraind, T. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06779-1 · Cited by 188
Hall, D. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12715-0 · Cited by 187
Determining the Potency and Molecular Mechanism of Action of Insurmountable Antagonists
Kenakin, T., Jenkinson, S., & Watson, C. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107375 · Cited by 174
Analysis of Allosterism in Functional Assays
Ehlert, F. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090886 · Cited by 168
Holst, B., Brandt, E. G. S., Bach, A., Heding, A., & Schwartz, T. W. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0059 · Cited by 124
Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox
Langmead, C. J., & Christopoulos, A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.009 · Cited by 117
Self-citationIdentification of Allosteric Peptide Agonists of CXCR4
Sachpatzidis, A., Benton, B. K., Manfredi, J. P., Wang, H., Hamilton, A. D., Dohlman, H. G., & Lolis, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204667200 · Cited by 117
Makita, N., Sato, J., Manaka, K., Shoji, Y., Oishi, A., Hashimoto, M., Fujita, T., & Iiri, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701290104 · Cited by 107
Lazareno, S., Doležal, V., Popham, A., & Birdsall, N. J. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.257 · Cited by 104
Mathiesen, J. M., Ulven, T., Martini, L., Gerlach, L. O., Heinemann, Á., & Kostenis, E. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.010520 · Cited by 100
Lagane, B., Ballet, S., Planchenault, T., Balabanian, K., Poul, E. L., Blanpain, C., Percherancier, Y., Staropoli, I., Vassart, G., Oppermann, M., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009779 · Cited by 99
Allosteric modulation of G-protein coupled receptors
Jensen, A. A., & Spalding, T. A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.11.007 · Cited by 98
Tateyama, M., & Kubo, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505925103 · Cited by 88
Ago-Allosteric Modulation and Other Types of Allostery in Dimeric 7TM Receptors
Schwartz, T. W., & Holst, B. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600567570 · Cited by 85
Durroux, T. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.006 · Cited by 83
Avlani, V. A., May, L. T., Sexton, P. M., & Christopoulos, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059840 · Cited by 53
Self-citationZahn, K., Eckstein, N., Tränkle, C., Sadée, W., & Mohr, K. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.720 · Cited by 46
Tilakaratne, N., & Sexton, P. M. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04295.x · Cited by 36
Self-citationFrancke, F., Ward, R. J., Jenkins, L., Kellett, E., Richter, D., Milligan, G., & Bächner, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602889200 · Cited by 34
Lanzafame, A., Christopoulos, A., & Mitchelson, F. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36766-7 · Cited by 32
Self-citationFunctional identification of Gd3+ binding site of metabotropic glutamate receptor 1α
Abe, H., Tateyama, M., & Kubo, Y. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00569-6 · Cited by 29
Christopoulos, A., Lanzafame, A. A., Ziegler, A., et al. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00814-3 · Cited by 28
Self-citation
Cited by
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citationTeaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Self-citationCommon activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
Metadata
- Authors
- Leach, K., Sexton, P. M., & Christopoulos, A.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 28
- Issue
- 8
- Pages
- 382-389
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W1976266427
- Cited by
- 363
- References
- 44
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.